UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000063549
Receipt number R000072723
Scientific Title A Study on the Effects of a Children's Oral Exercise Program on Oral Development
Date of disclosure of the study information 2026/11/20
Last modified on 2026/11/06 17:23:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effects of a Children's Oral Exercise Program on Oral Development

Acronym

A Study on the Effects of a Children's Oral Exercise Program on Oral Development

Scientific Title

A Study on the Effects of a Children's Oral Exercise Program on Oral Development

Scientific Title:Acronym

A Study on the Effects of a Children's Oral Exercise Program on Oral Development

Region

Japan


Condition

Condition

Healthy school children

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of oral exercises on the development of oral function in elementary school students

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Oral function assessment, Developmental Insufficiency of Oral Function, Parent questionnaire, Height, Weight

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food Behavior,custom

Interventions/Control_1

Oral Training

Interventions/Control_2

No treatment

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

7 years-old <=

Age-upper limit

9 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Individuals who have obtained informed consent from a parent or guardian, or informed assent from the participant themselves
(2) Individuals who are able to consume the test food
(3) Individuals who do not have any allergies to the test food
(4) Individuals who have the capacity to understand and consent to the purpose and content of the study, and who have a parent or guardian who can voluntarily provide written consent for their participation in this study

Key exclusion criteria

(1) Individuals deemed unsuitable for this trial by the principal investigator
(2) Individuals who underwent treatments that significantly affect oral function-such as orthodontic treatment or oral myofunctional therapy-during the exam period

Target sample size

66


Research contact person

Name of lead principal investigator

1st name Kazuto
Middle name
Last name Okabayashi

Organization

LOTTE CO.,LTD

Division name

Research and Development Center, Kamukoto Research Department

Zip code

3368601

Address

1-1 Numakage 3-chome, Minami-ku, Saitama

TEL

048-837-0744

Email

Okabayashi_kazuto@lotte.co.jp


Public contact

Name of contact person

1st name Kazuto
Middle name
Last name Okabayashi

Organization

Lotte Co., Ltd.

Division name

Research and Development Center, Kamukoto Research Department

Zip code

3368601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0744

Homepage URL


Email

okabayashi_kazuto@lotte.co.jp


Sponsor or person

Institute

Lotte Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Lotte Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic

Address

6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

Tel

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 11 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 11 Month 12 Day

Date of IRB

2026 Year 11 Month 12 Day

Anticipated trial start date

2027 Year 01 Month 16 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 11 Month 06 Day

Last modified on

2026 Year 11 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072723